QuiVad

Home / Denmark / ChemoMetec A/S

ChemoMetec A/S

Short position disclosed on July 22, 2026.

Follow

Evolution of the disclosed total

0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 0.68% on July 22, 2026. The shaded band matches the twelve months of the first chart.

April 21, 2022 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Citadel Advisors LLC0.68%newJuly 22, 2026

In the United States CHHMF (OTC): 12,705 shares sold short on August 31, 2026. FINRA names no fund.

On the other side: the funds that hold ChemoMetec A/S Titelia

Follow by RSS

Get the moves on ChemoMetec A/S by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

197 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 15, 2024Qube Research & Technologies Ltd0.95%April 15, 2024
April 15, 2024Brummer Multi-Strategy AB0.86%April 15, 2024
April 12, 2024Qube Research & Technologies Ltd0.85%April 12, 2024
April 12, 2024Brummer Multi-Strategy AB0.79%April 12, 2024
April 8, 2024Qube Research & Technologies Ltd0.78%April 8, 2024
April 4, 2024Qube Research & Technologies Ltd0.82%April 4, 2024
April 4, 2024Marshall Wace LLP0.49%April 4, 2024
April 3, 2024Pertento Partners LLP0.71%April 3, 2024
April 2, 2024Qube Research & Technologies Ltd0.97%April 2, 2024
March 22, 2024Marshall Wace LLP0.57%March 22, 2024
March 20, 2024Marshall Wace LLP0.68%March 20, 2024
March 19, 2024Qube Research & Technologies Ltd1.09%March 19, 2024
March 19, 2024Marshall Wace LLP0.71%March 19, 2024
March 15, 2024Qube Research & Technologies Ltd1.16%March 15, 2024
March 15, 2024Marshall Wace LLP0.66%March 15, 2024
March 13, 2024Marshall Wace LLP0.74%March 13, 2024
March 12, 2024Qube Research & Technologies Ltd1.29%March 12, 2024
March 8, 2024Qube Research & Technologies Ltd1.32%March 8, 2024
March 7, 2024Marshall Wace LLP0.58%March 7, 2024
March 6, 2024Qube Research & Technologies Ltd1.28%March 6, 2024
March 5, 2024Brummer Multi-Strategy AB0.97%March 5, 2024
March 5, 2024Boone Capital Management LLC0.67%March 5, 2024
March 5, 2024Marshall Wace LLP0.62%March 5, 2024
March 1, 2024Qube Research & Technologies Ltd1.31%March 1, 2024
February 29, 2024Brummer Multi-Strategy AB1.15%February 29, 2024
February 22, 2024Qube Research & Technologies Ltd1.21%February 22, 2024
February 22, 2024Marshall Wace LLP0.50%February 22, 2024
February 15, 2024Qube Research & Technologies Ltd1.18%February 15, 2024
February 15, 2024Boone Capital Management LLC0.79%February 15, 2024
February 12, 2024Qube Research & Technologies Ltd1.28%February 12, 2024
February 8, 2024Qube Research & Technologies Ltd1.32%February 8, 2024
February 7, 2024Qube Research & Technologies Ltd1.27%February 7, 2024
February 5, 2024Qube Research & Technologies Ltd1.09%February 5, 2024
February 1, 2024Boone Capital Management LLC0.88%February 1, 2024
January 29, 2024Qube Research & Technologies Ltd1.11%January 29, 2024
January 26, 2024Qube Research & Technologies Ltd1.02%January 26, 2024
January 12, 2024Qube Research & Technologies Ltd0.91%January 12, 2024
January 11, 2024Qube Research & Technologies Ltd0.82%January 11, 2024
December 29, 2023Qube Research & Technologies Ltd0.79%December 29, 2023
December 21, 2023Qube Research & Technologies Ltd0.89%December 21, 2023
December 20, 2023Boone Capital Management LLC0.99%December 20, 2023
December 18, 2023Qube Research & Technologies Ltd0.91%December 18, 2023
December 15, 2023Qube Research & Technologies Ltd0.89%December 15, 2023
December 14, 2023Qube Research & Technologies Ltd0.77%December 14, 2023
December 8, 2023Qube Research & Technologies Ltd0.86%December 8, 2023
November 30, 2023Qube Research & Technologies Ltd0.96%November 30, 2023
November 21, 2023Qube Research & Technologies Ltd1.00%November 21, 2023
November 10, 2023Pertento Partners LLP0.63%November 10, 2023
November 3, 2023Qube Research & Technologies Ltd0.93%November 3, 2023
November 2, 2023Brummer Multi-Strategy AB1.27%November 2, 2023

Download 197 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Denmark

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, ChemoMetec A/S, source Finanstilsynet, data as at July 22, 2026, https://www.quivad.com/action/chemometec-a-s?page=3